| Literature DB >> 35210525 |
Mohamed O Amin1, Entesar Al-Hetlani2, Igor K Lednev3.
Abstract
Recent advancements in analytical techniques have greatly contributed to the analysis of latent fingermarks' (LFMs) "touch chemistry" and identification of materials that a suspect might have come into contact with. This type of information about the FM donor is valuable for criminal investigations because it narrows the pool of suspects. It is estimated that at least 30 million people around the world take over-the-counter and prescription nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief, headaches and arthritis every day. The daily use of such drugs can lead to an increased risk of their abuse. In the present study, Raman spectroscopy combined with multivariate statistical analysis was used for the detection and identification of drug traces in LFMs when NSAID tablets of aspirin, ibuprofen, diclofenac, ketoprofen and naproxen have been touched. Partial least squares discriminant analysis of Raman spectra showed an excellent separation between natural FMs and all NSAID-contaminated FMs. The developed classification model was externally validated using FMs deposited by a new donor and showed 100% accuracy on a FM level. This proof-of-concept study demonstrated the great potential of Raman spectroscopy in the chemical analysis of LFMs and the detection and identification of drug traces in particular.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35210525 PMCID: PMC8873478 DOI: 10.1038/s41598-022-07168-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The average Raman spectra of natural fingermark and fingermarks contaminated with aspirin, diclofenac, ketoprofen, ibuprofen or naproxen tablets. The experimental spectra were preprocessed by baseline correction and normalization.
Raman band assignment for the natural and NSAID-contaminated fingermarks. The asterisks (*) indicate regions selected using the GA method.
| Raman band (cm−1) | Source | Band assignment | Ref |
|---|---|---|---|
| 1655 | Eccrine | C=O stretching (secondary amide) | [ |
| 1629 | Naproxen | Ring stretching, | [ |
| 1606* | Aspirin | Ring stretching and OH bending | [ |
| 1606* | Ibuprofen | Ring stretching | [ |
| 1606* and 1578 | Diclofenac | Ring stretching | [ |
| 1598* | Ketoprofen | C–C stretching (ring) | [ |
| 1485*, 1420* and 1168 | Naproxen | CH bending | [ |
| 1439 | Sebaceous | CH2 and CH3 deformation (aliphatic carbon chain) | [ |
| 1307 | Sebaceous | CH2 twisting (aliphatic carbon chain) | [ |
| 1267 | Sebaceous | = CH deformation (Squalene, unsaturated fatty acid, glycerides and wax esters | [ |
| 1250 | Diclofenac | C–C stretching CH rock, | [ |
| 1236 | Diclofenac | C–N–C stretching, CH rock, C7H2 wagging | [ |
| 1207* and 1180 | Ibuprofen | CH bending and OH bending, | [ |
| 1194* | Ketoprofen | Ring deformation and C–C stretching | [ |
| 1194* | Aspirin | Φ, COC stretching (Φ: ring) | [ |
| 1178* | Naproxen | HCC in plane bending | [ |
| 1159* | Aspirin | CH and OH in-plane bending | [ |
| 1159* | Diclofenac | CH bending (ring) | [ |
| 1138* | Ketoprofen | Φ -C- Φ symmetric stretch (Φ: ring) | [ |
| 1124 and 1078 | Sebaceous | C–C stretching (aliphatic carbon chain) | [ |
| 1116 | Ibuprofen | CH bending and OH bending, | [ |
| 1073* and 1045* | Diclofenac | Ring breathing | [ |
| 1045* | Aspirin | C–H bending | [ |
| 1031* | Ketoprofen | CH in-plane bending | [ |
| 1009* | Ibuprofen | CH in-plane bending | [ |
| 1002* | Ketoprofen | Ring deformation and CH3 rocking | [ |
| 1002 | Eccrine | Ring breathing (phenyl alanine) | [ |
| 961 | Naproxen | Torsion-HCCH | [ |
| 861* | Diclofenac | CH twisting | [ |
| 860* | Eccrine | Para-substituted ring vibration (Tyrosine) | [ |
| 748* | Naproxen | Torsion-HCCC | [ |
| 720* | Diclofenac | CH wagging | [ |
| 704* | Ketoprofen | CH out-of-plane bending | [ |
| 524 | Naproxen | HCC in-plane bending, Torsion-HCOC, Torsion-HCCO | [ |
Figure 2PCA scatter plot for individual Raman spectra of natural and NSAID-contaminated fingermarks.
Figure 3Cross validation prediction results of the PLS-DA model of each classification group using five latent variables: natural fingermark (red) and aspirin (green), diclofenac (navy blue), ibuprofen (light blue), ketoprofen (pink), and naproxen (orange) contaminated fingermarks (A) before applying GA and (B) after using the regions selected by GA.
Figure 4Strict prediction results of the PLS-DA classification model for natural FM- and NSAID-contaminated FMs based on five latent variables using regions selected by GA. The left side of the plot shows the calibration results based on the training dataset. The right side of the plot shows the external validation tests from an independent donor.
A confusion matrix for individual spectra obtained for the external validation of the PLS-DA model based on five latent variables using the regions selected by the GA method.
| Class predicted | Actual class | |||||
|---|---|---|---|---|---|---|
| Natural FM | Aspirin tablet FM | Diclofenac tablet FM | Ibuprofen tablet FM | Ketoprofen tablet FM | Naproxen tablet FM | |
| Natural FM | 28 | 0 | 0 | 0 | 0 | 0 |
| Aspirin tablet FM | 0 | 20 | 0 | 0 | 0 | 0 |
| Diclofenac tablet FM | 0 | 0 | 18 | 0 | 0 | 0 |
| Ibuprofen tablet FM | 0 | 0 | 0 | 22 | 0 | 0 |
| Ketoprofen tablet FM | 0 | 0 | 0 | 0 | 23 | 0 |
| Naproxen tablet FM | 0 | 0 | 0 | 0 | 0 | 19 |
| Unclassified | 2 | 3 | 1 | 0 | 1 | 0 |